Table 1.
Baseline characteristics.a
| Parameters | Intervention (n=100) | Usual care (n=49) | |
| Age (years), mean (SD) | 60.0 (8.9) | 61.1 (8.6) | |
| Male gender, n (%) | 84 (84) | 36 (73) | |
| Active smoker, n (%) | 22 (22) | 11 (22) | |
| Physiological measures | |||
|
|
SBPb (mm Hg), mean (SD) | 150.0 (27.6) | 142.9 (25.5) |
|
|
DBPc (mm Hg), mean (SD) | 88.5 (14.6) | 86.8 (14.8) |
|
|
Waist circumference (cm), mean (SD) | 104.9 (12.9) | 104.5 (13.9) |
|
|
Weight (kg), mean (SD) | 86.3 (15.1) | 85.3 (16.2) |
|
|
BMI (kg/m2), median (IQR) | 27 (25-30) | 27 (25-29) |
| Laboratory measures | |||
|
|
Total cholesterol (mmol/L), mean (SD) | 4.7 (1.1) | 4.9 (1.1) |
|
|
LDLd-cholesterol (mmol/L), mean (SD) | 2.8 (0.9) | 3 (1.0) |
|
|
Triglycerides (mmol/L), median (IQR) | 1.4 (0.9-2.1) | 1.4 (1.0-1.9) |
|
|
HDLe-cholesterol (mmol/L), median (IQR) | 1.2 (0.9-1.4) | 1.2 (0.9-1.4) |
|
|
Fasting plasma glucose (mmol/L), median (IQR) | 7.5 (6.4-9.2) | 7.1 (6.2-8.9) |
|
|
HbA1cf (mmol/mol), median (IQR) | 38 (34.5-41.0) | 39 (36.0-42.0) |
| Previous disease, n (%) | |||
|
|
Ischemic heart disease (previous MIg, PCIh, or CABGi) | 18 (18) | 6 (12) |
|
|
Heart failure | 5 (5) | 0 (0) |
|
|
Diabetes mellitus | 9 (9) | 6 (12) |
|
|
Hypertension | 42 (42) | 17 (34) |
| Medication on hospital admission, n (%) | |||
|
|
ACEij or ARBk | 36 (36) | 12 (24) |
|
|
Statins | 24 (24) | 5 (10) |
|
|
Acetylsalicylic acid | 18 (18) | 5 (10) |
|
|
β-blockers | 19 (19) | 7 (14) |
| Medication at hospital discharge, n (%) | |||
|
|
ACEi or ARB | 95 (95) | 46 (93) |
|
|
Statins | 100 (100) | 47 (95) |
|
|
DAPTl | 100 (100) | 49 (100) |
|
|
β-blockers | 89 (89) | 43 (87) |
| Type of MI, n (%) | |||
|
|
STEMIm | 59 (59) | 24 (48) |
|
|
NSTEMIn | 41 (41) | 24 (48) |
aData are presented as n (%), mean (SD), or median (IQR).
bSBP: systolic blood pressure.
cDBP: diastolic blood pressure.
dLDL: low-density lipoprotein.
eHDL: high-density lipoprotein.
fHbA1c: glycated hemoglobin A1c.
gMI: myocardial infarction.
hPCI: percutaneous coronary intervention.
iCABG: coronary artery bypass grafting.
jACEi: angiotensin-converting enzyme inhibitor.
kARB: angiotensin II receptor blocker.
lDAPT: dual antiplatelet therapy.
mSTEMI: ST elevation myocardial infarction.
nNSTEMI: non-ST elevation myocardial infarction.